Table 1.
Clinical characteristics of ten patients with Coronavirus 19 severe acute respiratory distress syndrome
| Variables | |
|---|---|
| Age (years) | 60 (52–72) |
| Female gender | 3 (30%) |
| Body mass index (kg/m2) | 28.2 (22.0–37.4) |
| Comorbidities | |
| Dyslipidemia | 2 (20%) |
| Current smoker | 2 (20%) |
| Arterial hypertension | 5 (50%) |
| Diabetes mellitus | 5 (50%) |
| Atrial fibrillation | 0 |
| Heart failure | 0 |
| Previous stroke | 0 |
| COPD | 1 (10%) |
| Cirrhosis | 0 |
| Dialysis | 1 (10%) |
| Previous stroke | 0 |
| Standard treatments | |
| Anticoagulant | 0 |
| Antiplatelet therapy | 0 |
| ACE inhibitors or ARB | 5 (50%) |
| Organ failure at admission | |
| Charlson comorbidity index | 2 (0–2) |
| SAPS-II | 36 (32–46) |
| SOFA score | 6 (3–7) |
| PaO2/FiO2 | 112 (92–144) |
| Neuromuscular-blocking agent use | 7 (70%) |
| Shock | 1 (10%) |
Values are expressed as median (interquartile range)
C-ARDS COVID-19 ARDS patients, ARDS: acute respiratory distress syndrome, COPD chronic obstructive pulmonary disease, ACE angiotensin-converting enzyme, ARB angiotensin receptors blockers, SAPS II Simplified Acute Physiology Score II, SOFA score Sequential Organ Failure Assessment, PaO2 arterial oxygen tension, FiO2 fraction of inspired oxygen